Key takeaways:
Glucagon-like peptide-1 (GLP-1) medications start changing your appetite within the first week or two. But visible weight loss builds slowly over the following months as your dose increases.
Most people see real weight loss once they reach an effective dose about 1 to 4 months after starting a GLP-1. Your weight typically keeps dropping until it levels off somewhere around 12 to 18 months.
If you haven’t lost at least 5% of your body weight after a few months at your full dose, check in with your prescriber. You may be a non-responder to that GLP-1 and might need your medication or treatment plan adjusted.
Save on related medications
If you’ve just started a GLP-1 like Ozempic and Wegovy (semaglutide) or Zepbound (tirzepatide), you probably want to know one thing: When will it actually work? The honest answer is that these medications work in stages. Your appetite usually shifts within days. The number on the scale takes longer. And your biggest results are most often months away, not weeks.
Here's a realistic timeline of when to expect weight loss while taking a GLP-1 and what to do if things feel slow.
How long does it take for GLP-1s to work?
GLP-1s don't work overnight, but they don't take forever either. Appetite changes usually come first. These medications reduce how much you eat mainly by curbing your appetite. GLP-1s like semaglutide can reach peak levels within a few days of your first dose. As a result, many people feel less hungry within the first week.
Weight loss shows up more gradually, and that's partly by design. The starting dose for GLP-1s is low and then raised step by step over about 4 months to limit side effects. In the clinical trials for semaglutide, weight came off steadily over many months rather than all at once.
Here's the general timeline for weight loss when taking a GLP-1.
Timeframe | What's typically happening |
|---|---|
First 1 to 2 weeks (starting dose) | Your body is learning how to respond to the medication, and your appetite may start to drop. |
First month (starting dose) | You may start to feel full sooner and think about food less. You may notice minimal weight loss and side effects like nausea. |
Months 1 to 4 (dose increasing) | Weight loss may become more noticeable and increase as you reach an effective dose. |
Months 4 to 12 (effective dose) | The bulk of your weight loss may happen during this stretch. Some may begin to notice a weight-loss plateau after 6 months, based on your starting weight and current dose. |
12 to 18 months and beyond | Most people will notice that weight loss may plateau or level off. |
The exact pace for your weight loss depends on which medication you take, the dose, and how your body responds.
How do GLP-1s work?
GLP-1 medications copy a natural gut hormone that your body releases when you eat. Here’s how GLP-1s work:
They signal your brain to feel less hungry and more full.
They slow how fast your stomach empties, so meals keep you satisfied longer.
Some, like tirzepatide, also mimic a second hormone — glucose-dependent insulinotropic polypeptide (GIP) — for an added effect.
The result is that you eat less without really noticing it.
What are the first few weeks like on GLP-1s?
The first few weeks of taking a GLP-1 are mostly about your body adjusting, not about the weight on the scale.
You'll start at a low “starter” dose:
For Wegovy, that's 0.25 mg once a week for the injection, or 1.5 mg daily for the Wegovy pill.
If you’re prescribed Zepbound for weight loss, the starting dose is 2.5 mg.
The starter dose is too low to drive much weight loss. Its job is to let your system get used to the medication so you have fewer side effects as your dose increases. Your prescriber will then raise the dose every 4 weeks, reaching your full dose after roughly 4 to 5 months.
What are the earliest changes you'll notice?
The first thing most people notice isn't weight — it's appetite. Within days to a couple of weeks, you may notice:
Hunger tending to fade
Feeling fuller faster
Less constant thoughts about food (sometimes called “food noise”)
You may also notice side effects during this stretch, like:
Nausea
Diarrhea
Constipation
Upset stomach
These side effects are common early on and usually ease as your body adjusts. Eating smaller meals and avoiding rich, fatty foods can help.
How can you tell if it's working?
Weight loss won’t usually happen right away while taking a GLP-1, but there will be signs that your medication is working. The early signs a GLP-1 is working are:
Decreased appetite
Eating less
Feeling satisfied with smaller portions
When does noticeable weight loss start on GLP-1s?
Most people can expect to lose more than 5% of their body weight within the first few months while taking a GLP-1 at an effective dose. But it’s important to note that everyone’s response is different. If you haven’t lost at least 5% of your starting weight by week 20, you may be a non-responder. If you're well past that point at a full dose and the scale still hasn't budged, it's worth a conversation with your prescriber about the next steps.
Don't judge your success of taking a GLP-1 by your first month or two. You're still taking the starter dose during this time. So, early weight loss is usually small and varies a lot from person to person. Some people who don’t respond to a GLP-1 initially can go on to lose weight within an additional 6 months. Others may need to consider another medication or treatment plan.
How long until you reach your maximum results on a GLP-1?
Your biggest results will likely take the better part of a year. People taking semaglutide lost about 15% of their body weight over 68 weeks. The time frame for maximum results is similar for tirzepatide. In clinical trials, people lost up to about 21% of their body weight over 72 weeks.
Depending on your GLP-1, some people begin to hit a plateau roughly somewhere between 6 and 12 months. With tirzepatide, weight loss for about 9 in 10 people leveled off at 18 months.
How can you lose the most weight on GLP-1s?
A few things can make a real difference in how your weight-loss journey goes. Use these tips to make sure you get the most out of your GLP-1 use:
Get to an effective dose and stay with it. The starter dose isn't meant to produce big results. Most of the benefit comes at the higher maintenance doses, so work with your prescriber to find the best dose for you.
Protect your muscles. A significant amount of the weight lost while taking GLP-1s comes from losing lean mass, not just fat. Eating enough protein and doing regular strength training helps you hold onto muscle and lose more fat.
Be mindful of your diet. Prioritize protein, fiber, and whole foods. Limit ultra-processed food and alcohol. These are fundamental dietary things to focus on, and they’ll help you tolerate a higher dose and keep the weight off.
Why might you not be losing weight on your GLP-1?
If the scale is stuck, there a few common reasons you may not be losing weight while taking your GLP-1, like:
Your dose is too low. It might be that you're still taking a low dose and haven't reached an effective dose yet.
You've hit a plateau. This is normal after several months to a year, as your body adapts to the medication and burns fewer calories.
You have other medical factors. Taking another medication, or having a condition like Type 2 diabetes or a thyroid problem, is making weight loss harder.
You're simply a lower responder. About 10% to 15% of people don't lose much weight while taking these drugs, even when everything is done right.
If you've plateaued and still want to lose more weight, your prescriber may adjust your dose, tweak your routine, or switch you to a different GLP-1.
Frequently asked questions
The best glucagon-like peptide-1 (GLP-1) for you depends on a lot of factors. In clinical trials, people taking tirzepatide lost around 20% of their body weight over 72 weeks. That’s compared to about 14% weight loss for those taking semaglutide.
That said, choosing the right GLP-1 for you should take into account cost, side effects, personal preference, and how your individual body responds. Talk to a healthcare professional about which GLP-1s may work best for you.
GLP-1s approved for weight loss are generally an option if you have a body mass index (BMI) of 30 or higher — or if you have a BMI of 27 or higher along with a weight-related condition like high blood pressure or Type 2 diabetes. They shouldn't be used if you have a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2 (MEN2). Your prescriber will help decide if one is right for you.
The most common side effects are gastrointestinal, like:
Nausea
Diarrhea
Vomiting
Constipation
Less commonly, GLP-1s can cause gallbladder problems and, rarely, pancreatitis. They also carry an FDA black box warning about thyroid tumors due to results seen in rodent studies. However, it's unknown whether this applies to people or not.
Yes, many people tend to regain the weight they’ve lost after stopping their GLP-1 medication. In some clinical trials, people who stopped semaglutide regained about two-thirds of the weight they'd lost within a year. These medications are generally meant for long-term use.
The best glucagon-like peptide-1 (GLP-1) for you depends on a lot of factors. In clinical trials, people taking tirzepatide lost around 20% of their body weight over 72 weeks. That’s compared to about 14% weight loss for those taking semaglutide.
That said, choosing the right GLP-1 for you should take into account cost, side effects, personal preference, and how your individual body responds. Talk to a healthcare professional about which GLP-1s may work best for you.
GLP-1s approved for weight loss are generally an option if you have a body mass index (BMI) of 30 or higher — or if you have a BMI of 27 or higher along with a weight-related condition like high blood pressure or Type 2 diabetes. They shouldn't be used if you have a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2 (MEN2). Your prescriber will help decide if one is right for you.
The most common side effects are gastrointestinal, like:
Nausea
Diarrhea
Vomiting
Constipation
Less commonly, GLP-1s can cause gallbladder problems and, rarely, pancreatitis. They also carry an FDA black box warning about thyroid tumors due to results seen in rodent studies. However, it's unknown whether this applies to people or not.
Yes, many people tend to regain the weight they’ve lost after stopping their GLP-1 medication. In some clinical trials, people who stopped semaglutide regained about two-thirds of the weight they'd lost within a year. These medications are generally meant for long-term use.
The bottom line
It can take some time to notice weight loss after starting to take a glucagon-like peptide-1 (GLP-1) medication. The effects of these medications can appear in phases. Most people notice appetite shifts within the first week or two. But noticeable weight loss happens after you reach an effective dose within the first few months. Your biggest weight-loss results are likely to occur within 4 to 12 months before leveling off. If it seems like your weight loss is slow, talk to your prescriber. They can suggest the best next steps for you to achieve your weight-loss goals.
Why trust our experts?
References
Aronne, L. J., et al. (2025). Tirzepatide as compared with semaglutide for the treatment of obesity. The New England Journal of Medicine.
Farr, O. M., et al. (2016). GLP-1 receptors exist in the parietal cortex, hypothalamus and medulla of human brains and the GLP-1 analogue liraglutide alters brain activity related to highly desirable food cues in individuals with diabetes: A crossover, randomised, placebo-controlled trial. Diabetologia.
Horn, D. B., et al. (2025). Time to weight plateau with tirzepatide treatment in the SURMOUNT-1 and SURMOUNT-4 clinical trials. Clinical Obesity.
Jastreboff, A. M., et al. (2022). Tirzepatide once weekly for the treatment of obesity. The New England Journal of Medicine.
Martin, C. K., et al. (2025). Tirzepatide on ingestive behavior in adults with overweight or obesity: A randomized 6-week phase 1 trial. Nature Medicine.
Mosenzon, O., et al. (2021). Clinically-relevant weight loss is achieved independently of early weight loss response to once-weekly subcutaneous semaglutide 2.4 mg (STEP 4). Journal of the Endocrine Society.
National Cancer Institute. (2019). Medullary thyroid cancer (MTC).
National Cancer Institute. (2025). Multiple endocrine neoplasia type 2 (men2) (pdq®)–health professional version.
Noronha, J. C., et al. (2025). Optimizing GLP-1 therapies for obesity and diabetes management. Obesity Pillars.
Reiss, A. B., et al. (2025). Weight reduction with GLP-1 agonists and paths for discontinuation while maintaining weight loss. Biomolecules.
Rossi, G., et al. (2026). Muscle loss and GLP-1R agonists use. Acta Diabetologica.
Rubino, D., et al. (2021). Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: The STEP 4 randomized clinical trial. JAMA.
Wilding, J. P. H., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. The New England Journal of Medicine.
Wilding, J. P. H., et al. (2022). Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes, Obesity & Metabolism.
